Oral pathoses caused by Candida albicans during chemotherapy Update on development mechanisms

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 82, Issue 2, 1996, Pages 161-165

  Bunetel, Laurence ^a,b   Bonnaure Mallet, Martine ^a  

^a Equipe de Biologie Buccale Ea 1256   (France)

^b UFR d'Odontologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; BACTERIUM ADHERENCE; CANDIDA ALBICANS; DRUG EFFECT; ECOSYSTEM; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOLOGY; MICROBIOLOGY; MOUTH MUCOSA; PHYSIOLOGY; REVIEW; STREPTOCOCCUS; THRUSH;

ANIMALS; ANTINEOPLASTIC AGENTS; BACTERIAL ADHESION; CANDIDA ALBICANS; CANDIDIASIS, ORAL; ECOSYSTEM; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; MOUTH MUCOSA; STREPTOCOCCUS;

EID: 0030208267     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(96)80219-8     Document Type: Article

References (59)

1. Bergmann OJ. Oral infection and septicemia in immunocompromised patients with hematologic malignancies. J Med Microbiol 1988;26:2105-9.
2. Bergmann OJ, Kilian M, Ellegaard J. Potentially pathogenic microorganisms in the oral cavity during febrile episodes in immunocompromised patients with haematologic malignancies. Scand J Infect Dis 1989;21:43-51.
3. Zegarelli DJ. Fungal infections in the oral cavity. Otolaryngol Clin North Am 1993;26:1069-89.
4. Toth BB, Martin JW, Fleming TJ. Oral complications associated with cancer therapy. J Clin Periodontol 1990;17:508-15.
5. Fayle SA, Curzon MEJ. Oral complications in pediatric oncology patient. Pediatric Dentistry. 1991;13:289-94.
6. Williams MC, Martin MV. A longitudinal study of the effects on the oral mucosa of treatment for acute childhood leukaemia. Inter J Paed Dent 1992;2:73-9.
7. Scully C, MacFarlane TW. Orofacial manifestations of childhood malignancy: clinical and microbiological findings during remission. ASDC J Dent Child 1983;50:121-5.
8. Wingard JR. Infectious and noninfectious systemic consequences. NCI Monogr 1990;9:21-6.
9. Fleming P. Dental management of the pediatric oncology patient. Curr Op Dent 1991;1:577-82.
10. Dreizen S. Description and incidence of oral complications. NCI Monogr 1990;9:11-5.
11. Rosenberg SW. Oral care of chemotherapy patients. Dent Clin North Am 1990;34:239-50.
12. Mealey BL, Semba SE, Hallmon WW. Dentistry and the cancer patient: part 1, oral manifestations and complication of chemotherapy. Compendium 1994;15:1252-61.
13. Woo SB, Sonis ST, Monopoli M, Sonis A. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993;72:1612-7.
14. Borgmann A, Emminger W, Emminger-Schmidmeier W, Peters C, Gatterer-Menz I, Henze G, et al. Influence of fractionated total body irradiation on mucosal toxicity in intensified conditioning regimens for autologous bone marrow transplantation in pediatric cancer patients. Klin-Padiatr 1994;4:299-302.
15. Sonis ST, Lindquist L, Van Vugt A, Stewart AA, Stam K, Qu GY, et al. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor B3 1. Cancer Res 1994;54:1135-8.
16. Sonis ST, Costa JW, Evitts SM, Nicolson M, Oaks T. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol 1992;74:749-55.
17. Woods DE, Straus DC, Johanson WG, Bass JA. Role of salivary protease activity in adherence of Gram-negative bacilli to mammalian buccal epithelial cells in vitro. J Clin Invest 1981;68:1435-40.
18. O'Sullivan EA, Bailey CC, Hart P. Changes in the microflora during cytotoxic chemotherapy in children being treated for acute leukemia. Oral Surg Oral Med Oral Pathol 1993;76:161-8.
19. Bergmann OJ. Alterations in oral microflora and pathogenesis of acute oral infections during remission-induction therapy in patients with acute myeloid leukaemia. Scand J Infect Dis 1991;23:355-66.
20. Bergmann OJ, Andersen PL. Acute oral candidiasis during febrile episodes in immunocompromised patients with haematologic malignancies. Scand J Infect Dis 1990;22:353-8.
21. Epstein JB, Komiyama K, Duncan D. Oral topical steroids and secondary oral candidiasis. J Oral Med 1986;41:223-7.
22. Thongprasom K, Luanjjamekorn L, Serenat T, Taweesap W. Relative efficacy of fluocinalone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 1992;21:456-8.
23. Deslauriers N, Coulomoe C, Carré B, Goutet JP. Topical application of a corticostt roid destabilizes the host-parasite relationship in a experimental model of the oral carrier state of Candida albicans. FEMS Immunol Med Microbiol 1995;11:45-6.
24. Minah GE, Rednor JL, Peterson DE, Overholser CD, De Paola LG, Suzuki JB. Oral succession of Gram-negative bacilli in myelosuppressed cancer patients. J Clin Microbiol 1986;24:210-3.
25. Wahlin YB, Holm AK. Changes in the microflora in patients with acute leukemia ard related disorders during the period of induction therapy. Oral Surg Oral Med Oral Pathol 1988;65:411-7.
26. Tempro PJ, Nalbandian J. Colonization of retrieved polytetrafluoroethylene membranes: morphological and microbiological observations. J Periodontol 1993;64:162-8.
27. Darwazeh AM, Lamey PJ, MacFarlane TW, McCuish AC. The effect of exposure to chlorhexidine gluconate in vitro and in vivo on in vitro adhesion of Candida albicans to buccal epithelial cells from diabetic and non-diabetic subjects. J Oral Pathol Med 1994;23:130-2.
28. Luc J, Roques C, Frayret MN, Michel G, Ducani M, Vandermander J. Activité bactéricide in vitro de 5 antiseptiques buccaux vis-à-vis des principaux germes impliqués dans les affections bucco-dentaires. J Parodontol 1991;10:381-7.
29. Hase JC, Ainamo J, Etemadzadeh H, Astrom M. Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. J Clin Periodontol 1995;7:533-9.
30. Ferreti GA, Brown AT, Raybould TP, Lillich TT. Oral antimicrobial agents: chlothexidine. NCI Monogr 1990;9:51-5.
31. Ciancio S. Expanded and future uses of mouthrinses. J Am Dent Assoc 1994;125:29-32.
32. Audus KL, Tavakoli-Saberi MR, Zheng H, Boyce EN. Chlorhexidine effects on membrane lipid domains of human buccal epithelial cells. J Dent Res 1992;71:1298-303.
33. Spijkervet FKL, Van Saenc JJM, Van Saene HKF, Panders AK, Vermey A, Fidler V. Chlorhexidine inactivation by saliva. Oral Surg Oral Med Oral Pathol 1990;69:444-9.
34. Thurmond JM, Brown AT, Sims RE. Oral Candida albicans in bone marrow transplant patients given chlorhexidine rinses: occurrence and susceptibilities to the agent. Oral Surg Oral Med Oral Pathol 1991;72:291-5.
35. Järvinen H, Pienihäkkinen K, Huovinen P, Tenovuo J. Susceptibility of Streptococcus mutans and Streptococcus sobrinus to antimicrobial agents after short-term oral chlorhexidine treatments. Eur J Oral Sci 1995;103:32-5.
36. Langslet A, Olsen I, Lie SO, Lokken P. Chlorhexidine treatment of oral candidiasis in seriously diseased children. Acta Paediatr Scand 1974;65:809-11.
37. Ferretti GA, Raybould TP, Brown AT, Macdonald JS, Greenwood M. Maruyama Y, et al. Chlorhexidine prophylaxis for chemotherapy and radiotherapy-induced stomatitis: a randomized double-blind trial. Oral Surg Oral Med Oral Pathol 1990;69:331-8.
38. Rutkauskas JS, Davis JW. Effects of chlorhexidine during immunosuppressive chemotherapy. Oral Surg Oral Med Oral Pathol 1993;76:441-8.
39. Epstein JB, Vickars L, Spinelli J, Reece D. Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1992;73:682-9.
40. Meurman JH, Laine P, Murtomaa H, Lindqvist C, Torkko H, Teerenhovi L, et al. Effect of antiseptic mouthwashes on some clinical and microbiclogical findings in the mouths of lymphoma patients receiving cytostatic drugs. J Clin Periodontol 1991;18:587-91.
41. Wahlin YB. Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia. Oral Surg Oral Med Oral Pathol 1989;68:279-87.
42. Netuschil L, Weiger R, Preisler R, Brecx M. Plaque bacteria counts and vitality during chlorhexidine, meridol, and Listerine mouthrinses. Eur J Oral Sci 1995;103:355-61.
43. Budtz-Jorgensen E. Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infections. Acta Odontol Scand 1990;41:61-9.
44. Braga PC, Piatti G, Conti E, Vignali F. Effects of subinhibitory concentrations of Cyclopirox on the adherence of Candida albicans to human buccal and vaginal epithelial cells. Arzneim Forsch Drug Res 1992;42:1368-71.
45. Braga PC, Dal-Sasso M, Maci S, Piatti G, Dannhorn DR, Bonn M Inhibition of Candida albicans adhesiveness to human buccal and vaginal cells by sub-inhibitory concentrations of rilopirox. Arzneimittelforschung 1995;1:84-7.
46. Olsen I. Oral adhesion of yeasts. Acta Odontol Scand 1990;48:45-53.
47. Tronchin G, Bouchara JP, Annaix V, Robert R, Senet JM. Fungal cell adhesion molecules in Candida albicans. Eur J Epidemiol 1991;7:23-33.
48. Vargas K, Wertz PW, Drake D, Morrow B, Soil DR. Differences in adhesion of Candida albicans 3153 A cells exhibiting switch phenotypes to buccal epithelium and stratum corneum. Infect Immun 1994;62:1328-35.
49. Kennedy MJ, Johnson AM, Volz PA, Neely AN, Yancey RJ. Virulence and adhesive properties of serotypes A and B of Candida albicans isolated from paediatric burn patient. J Med Microbiol 1992;36:428-36.
50. Yu L, Lee KK, Sheth HB, Lane-Bell P, Srivastava G, Hindsgaul O, et al. Fimbria-mediated adherence of Candida albicans to glycosphingolipid receptors on human buccal epithelial cells. Infect Immun 1994;62:2843-8.
51. Sepulveda P, Murgui A, Lopez-Ribot JL, Casanova M, Timoneda J, Martinez JP. Evidence for the presence of collagenous domains in Candida albicans cell surface proteins. Infect Immun 1995;63:2173-9.
52. Bailey A, Wadsworth E, Calderone R. Adherence of Candida albicans to human buccal epithelial cells: host-induced protein synthesis and signalling events. Infect Immun 1995;63:569-72.
53. Lopez-Ribot J, Martinez JP, Chaffin WL. Comparative study of the C3d receptor and 58-kilodalton fibrinogen-binding mannoproteins of Candida albicans. Infect Immun 1995;63:2126-32.
54. Karaev ZO, Velichko EV, Bykov VL. Basic characteristics of the process of Candida adhesion to human epitheliocytes. Zh Microbiol Epidemiol Immunobiol 1986;7:59-61.
55. Eke PI, Rotimi VO, Laughon BE. Coaggregation of blackpigmented Bacteroides species with other oral bacteria. J Med Microbiol 1989;28:1-4.
56. Bagg J, Silverwood RW. Coagglutination reactions between Candida albicans and oral bacteria. J Med Microbiol 1986;22:165-9.
57. Hsu LY, Minah GE, Peterson DE, Wingard JR, Merz WG, Altomonte V, et al. Coaggregation of oral Candida isolates with bacteria from bone marrow transplant recipients. J Clin Microbiol 1990;28:2621-6.
58. Holmes AR, Gopal PK, Jenkinson HF. Adherence of Candida albicans to a cell surface polysaccharide receptor on Streptococcus gordonii. Infect Immun 1995;63:1827-34.
59. Axell T. The oral mucosa as a mirror of general health or disease. Scand J Dent Res 1992;100:9-16.